Faculty profile

Michael Parkins

ResearcherMedicineUniversity of Calgary

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.

Michael Parkins

Researcher

Medicine

Health Sciences

University of Calgary

Calgary, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2026.
Principal investigator on 12 research grants (12 CIHR), most recently in 2025.
Supervisor on 3 trainee awards (3 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Wastewater Covid-19 Sars-Cov2 Sewage Wastewater-Based Epidemiology Drug Poisonings Fentanyl Harm Reduction

Latest papers

Development and Validation of a Quantitative RT-qPCR Panel for the Detection and Monitoring of Polioviruses in Wastewater Samples.
Microorganisms · 2026
Early warning COVID-19 outbreak in long-term care facilities using wastewater surveillance: correlation, prediction, and interaction with clinical and serological statuses.
The Lancet. Microbe · 2024
A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment.
The European respiratory journal · 2024

All 12 publications

Latest funding

Developing wastewater-based surveillance tools to understand the changing nature of population-level substance use and reduce drug poisonings
CIHR · 2025 · Nominated PI
$1,231,649
Wastewater-based surveillance for substances of abuse: Developing actionable tools to inform on the dynamic nature of the drug supply
CIHR · 2024 · Nominated PI
$100,000
Canadian One Health Antimicrobial Resistance Health Research Training Network (CAN-AMR-Net)
CIHR · 2024 · Co-investigator
$2,700,000

All 19 grants and awards

12 publications.

Development and Validation of a Quantitative RT-qPCR Panel for the Detection and Monitoring of Polioviruses in Wastewater Samples.

Immaraj L, Qiu JY, Brand LA, Gao T, Lee B, Parkins M, Hubert C, O'Grady C, Pang X

Microorganisms2026

DOI: 10.3390/microorganisms14030709 PMID: 41900468

Early warning COVID-19 outbreak in long-term care facilities using wastewater surveillance: correlation, prediction, and interaction with clinical and serological statuses.

Pang X, Lee BE, Gao T, Rosychuk RJ, Immaraj L, Qiu JY, Wen J, Zelyas N, Howden K, Wallace J, Risling E, Little LA, Kim J, Wood H, Robinson A, Parkins M, Hubert CRJ, Frankowski K, Hrudey SE, Sikora C

The Lancet. Microbe2024

DOI: 10.1016/s2666-5247(24)00126-5 PMID: 39182502

A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment.

Waters V, Shaw M, Perrem L, Quon BS, Tullis E, Solomon M, Rayment JH, Lavoie A, Tse SM, Daigneault P, Bilodeau L, Price A, Nicholson M, Chin M, Parkins M, McKinney ML, Tam JS, Stanojevic S, Grasemann H, Ratjen F, (PIPE Study Investigators)

The European respiratory journal2024

DOI: 10.1183/13993003.02278-2023 PMID: 38697648

Wastewater surveillance monitoring of SARS-CoV-2 variants of concern and dynamics of transmission and community burden of COVID-19.

Hasing ME, Lee BE, Gao T, Li Q, Qiu Y, Ellehoj E, Graber TE, Fuzzen M, Servos M, Landgraff C, Delatolla R, Tipples G, Zelyas N, Hinshaw D, Maal-Bared R, Sikora C, Parkins M, Hubert CRJ, Frankowski K, Hrudey SE, Pang XL

Emerging microbes & infections2023

DOI: 10.1080/22221751.2023.2233638 PMID: 37409382

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification.

Mastromatteo S, Chen A, Gong J, Lin F, Thiruvahindrapuram B, Sung WWL, Whitney J, Wang Z, Patel RV, Keenan K, Halevy A, Panjwani N, Avolio J, Wang C, Côté-Maurais G, Bégin S, Adam D, Brochiero E, Bjornson C, Chilvers M, Price A, Parkins M, van Wylick R, Mateos-Corral D, Hughes D, Smith MJ, Morrison N, Tullis E, Stephenson AL, Wilcox P, Quon BS, Leung WM, Solomon M, Sun L, Ratjen F, Strug LJ

HGG advances2023

DOI: 10.1016/j.xhgg.2022.100156 PMID: 36386424

Natural killer cells kill extracellular Pseudomonas aeruginosa using contact-dependent release of granzymes B and H.

Feehan DD, Jamil K, Polyak MJ, Ogbomo H, Hasell M, Li SS, Xiang RF, Parkins M, Trapani JA, Harrison JJ, Mody CH

PLoS pathogens2022

DOI: 10.1371/journal.ppat.1010325 PMID: 35202434

Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.

Gong J, He G, Wang C, Bartlett C, Panjwani N, Mastromatteo S, Lin F, Keenan K, Avolio J, Halevy A, Shaw M, Esmaeili M, Côté-Maurais G, Adam D, Bégin S, Bjornson C, Chilvers M, Reisman J, Price A, Parkins M, van Wylick R, Berthiaume Y, Bilodeau L, Mateos-Corral D, Hughes D, Smith MJ, Morrison N, Brusky J, Tullis E, Stephenson AL, Quon BS, Wilcox P, Leung WM, Solomon M, Sun L, Brochiero E, Moraes TJ, Gonska T, Ratjen F, Rommens JM, Strug LJ

NPJ genomic medicine2022

DOI: 10.1038/s41525-022-00299-9 PMID: 35396391

Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

Lin Y-C, Keenan K, Gong J, Panjwani N, Avolio J, Lin F, Adam D, Barrett P, Bégin S, Berthiaume Y

Genetics in Medicine202129 citations

DOI: 10.1038/s41436-020-01073-x

Correction to: Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

Lin Y-C, Keenan K, Gong J, Panjwani N, Avolio J, Lin F, Adam D, Barrett P, Bégin S, Berthiaume Y

Genetics in Medicine2021

DOI: 10.1038/s41436-021-01281-z

Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States.

Thornton C, Somayaji R, Parkins M, Swain MG, Ramos KJ, Goss CH, Shaheen AA

The American journal of gastroenterology2021

DOI: 10.14309/ajg.0000000000001275 PMID: 33927124

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Wastewater Dear Professor Parkins, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Development and Validation of a Quantitative RT-qPCR Panel for the Detection and Monitoring of Polioviruses in Wastewater Samples." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Developing wastewater-based surveillance tools to understand the changing nature of population-level substance use and reduce drug poisonings" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Michael Parkins

Research

Latest papers

Latest funding

Development and Validation of a Quantitative RT-qPCR Panel for the Detection and Monitoring of Polioviruses in Wastewater Samples.

Early warning COVID-19 outbreak in long-term care facilities using wastewater surveillance: correlation, prediction, and interaction with clinical and serological statuses.

A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment.

Wastewater surveillance monitoring of SARS-CoV-2 variants of concern and dynamics of transmission and community burden of COVID-19.

High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification.

Natural killer cells kill extracellular Pseudomonas aeruginosa using contact-dependent release of granzymes B and H.

Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease.

Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

Correction to: Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth

Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States.

Developing wastewater-based surveillance tools to understand the changing nature of population-level substance use and reduce drug poisonings

Wastewater-based surveillance for substances of abuse: Developing actionable tools to inform on the dynamic nature of the drug supply

Canadian One Health Antimicrobial Resistance Health Research Training Network (CAN-AMR-Net)

CMV Immunity in the Healthy and Cystic Fibrosis Airway

Elevating wastewater surveillance into an advanced, diverse and inclusive platform for population health

The Impact of Cytomegalovirus on Cystic Fibrosis Airways Disease Severity

Variability in responses of antimicrobial resistance genes to lifting COVID-19-related measures among different population groups : A comparative study of the general public, university campus community, and marginalized groups

Dynamic surveillance for antimicrobial resistance in tertiary care hospitals through real-time wastewater monitoring

Wastewater-Based Epidemiology of SARS-CoV-2 in Tertiary Care Hospitals: Advancing Wastewater Science and Providing an Early-Warning System for Hospital Transmission and Outbreaks

Identifying and addressing barriers to cross-sectoral and community-based wastewater surveillance for the mitigation of secondary infections in rural and remote First Nations

Frequent collaborators

Felix Ratjen

Lei Sun

Ranjani Somayaji

Christopher Sikora

Xiaoli Pang

Mary Jackson

Tanja Gonska

Sanja Stanojevic

Elissa Rennert-May

Robert Delatolla

Christina Thornton

John Kim

Deena Hinshaw

Casey Hubert